For each of us, our unique biology is changing moment to moment. Yet, we only measure our biological state intermittently, almost exclusively in the confines of clinics, hospitals and doctor's offices.

​

This lack of scalable, longitudinal, on-demand data results in time and money wasted on suboptimal diagnostics, drugs, and failed clinical trials due to mismatches between treatments and human biology.

​

Legacy methods for patient data collection are also biased by limited population diversity — an increasingly important success factor for drug development and FDA approval.​